nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—Ethinyl Estradiol—osteoporosis	0.286	1	CrCtD
Danazol—SHBG—osteoporosis	0.083	0.415	CbGaD
Danazol—CYP19A1—osteoporosis	0.0609	0.305	CbGaD
Danazol—ESR1—osteoporosis	0.0561	0.28	CbGaD
Danazol—SHBG—Estropipate—osteoporosis	0.0351	0.162	CbGbCtD
Danazol—ESR1—Estropipate—osteoporosis	0.0254	0.117	CbGbCtD
Danazol—AR—Ergocalciferol—osteoporosis	0.0235	0.108	CbGbCtD
Danazol—SHBG—Ethinyl Estradiol—osteoporosis	0.0226	0.104	CbGbCtD
Danazol—ESR1—Raloxifene—osteoporosis	0.0169	0.0779	CbGbCtD
Danazol—Trilostane—Estradiol—osteoporosis	0.0169	0.0742	CrCrCtD
Danazol—ESR1—Ethinyl Estradiol—osteoporosis	0.0163	0.0753	CbGbCtD
Danazol—Formestane—Estropipate—osteoporosis	0.0157	0.0688	CrCrCtD
Danazol—Quinestrol—Estropipate—osteoporosis	0.0149	0.0653	CrCrCtD
Danazol—Mestranol—Estropipate—osteoporosis	0.0149	0.0653	CrCrCtD
Danazol—SHBG—Estradiol—osteoporosis	0.0146	0.0671	CbGbCtD
Danazol—Ethinyl Estradiol—Estropipate—osteoporosis	0.0142	0.0622	CrCrCtD
Danazol—CYP19A1—Raloxifene—osteoporosis	0.0137	0.0632	CbGbCtD
Danazol—Desogestrel—Ethinyl Estradiol—osteoporosis	0.0128	0.0561	CrCrCtD
Danazol—AR—Estradiol—osteoporosis	0.0122	0.0561	CbGbCtD
Danazol—ESR1—Conjugated Estrogens—osteoporosis	0.012	0.0552	CbGbCtD
Danazol—Formestane—Conjugated Estrogens—osteoporosis	0.0119	0.0521	CrCrCtD
Danazol—Mestranol—Conjugated Estrogens—osteoporosis	0.0113	0.0495	CrCrCtD
Danazol—Quinestrol—Conjugated Estrogens—osteoporosis	0.0113	0.0495	CrCrCtD
Danazol—Ethinyl Estradiol—Conjugated Estrogens—osteoporosis	0.0108	0.0471	CrCrCtD
Danazol—Etonogestrel—Ethinyl Estradiol—osteoporosis	0.0106	0.0463	CrCrCtD
Danazol—ESR1—Estradiol—osteoporosis	0.0105	0.0485	CbGbCtD
Danazol—Norelgestromin—Ethinyl Estradiol—osteoporosis	0.00999	0.0438	CrCrCtD
Danazol—Quinestrol—Estradiol—osteoporosis	0.00972	0.0426	CrCrCtD
Danazol—Mestranol—Estradiol—osteoporosis	0.00972	0.0426	CrCrCtD
Danazol—Mestranol—Ethinyl Estradiol—osteoporosis	0.00949	0.0416	CrCrCtD
Danazol—Quinestrol—Ethinyl Estradiol—osteoporosis	0.00949	0.0416	CrCrCtD
Danazol—Ethinyl Estradiol—Estradiol—osteoporosis	0.00926	0.0406	CrCrCtD
Danazol—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00827	0.0362	CrCrCtD
Danazol—Norethindrone—Ethinyl Estradiol—osteoporosis	0.00664	0.0291	CrCrCtD
Danazol—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.00545	0.0239	CrCrCtD
Danazol—Testosterone—Estradiol—osteoporosis	0.00497	0.0218	CrCrCtD
Danazol—CYP3A4—Estropipate—osteoporosis	0.0026	0.012	CbGbCtD
Danazol—CYP3A4—Calcitriol—osteoporosis	0.0026	0.012	CbGbCtD
Danazol—CYP3A4—Ergocalciferol—osteoporosis	0.00208	0.00959	CbGbCtD
Danazol—CYP3A4—Raloxifene—osteoporosis	0.00174	0.008	CbGbCtD
Danazol—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00168	0.00773	CbGbCtD
Danazol—CYP3A4—Cholecalciferol—osteoporosis	0.00134	0.00618	CbGbCtD
Danazol—CYP3A4—Conjugated Estrogens—osteoporosis	0.00123	0.00567	CbGbCtD
Danazol—CYP3A4—Estradiol—osteoporosis	0.00108	0.00498	CbGbCtD
Danazol—CCL2—Calcitriol—Ergocalciferol—osteoporosis	0.000559	0.54	CbGdCrCtD
Danazol—CCL2—Calcitriol—Cholecalciferol—osteoporosis	0.000475	0.459	CbGdCrCtD
Danazol—Trilostane—ESR2—osteoporosis	0.00015	0.0835	CrCbGaD
Danazol—Desogestrel—SHBG—osteoporosis	0.000135	0.0752	CrCbGaD
Danazol—Quinestrol—ESR1—osteoporosis	0.000122	0.0679	CrCbGaD
Danazol—Etonogestrel—SHBG—osteoporosis	0.000109	0.0609	CrCbGaD
Danazol—Testolactone—CYP19A1—osteoporosis	0.000107	0.0598	CrCbGaD
Danazol—Mestranol—ESR1—osteoporosis	9.23e-05	0.0514	CrCbGaD
Danazol—Trilostane—ESR1—osteoporosis	9.23e-05	0.0514	CrCbGaD
Danazol—Desogestrel—ESR1—osteoporosis	9.12e-05	0.0508	CrCbGaD
Danazol—Levonorgestrel—SHBG—osteoporosis	7.73e-05	0.0431	CrCbGaD
Danazol—Etonogestrel—ESR1—osteoporosis	7.38e-05	0.0411	CrCbGaD
Danazol—Fluoxymesterone—SHBG—osteoporosis	7.37e-05	0.0411	CrCbGaD
Danazol—Ethinyl Estradiol—ESR2—osteoporosis	7.14e-05	0.0398	CrCbGaD
Danazol—Pancreatitis—Estradiol—osteoporosis	7.01e-05	0.00156	CcSEcCtD
Danazol—Musculoskeletal discomfort—Estropipate—osteoporosis	7e-05	0.00156	CcSEcCtD
Danazol—Tension—Pamidronate—osteoporosis	6.94e-05	0.00155	CcSEcCtD
Danazol—Paraesthesia—Estropipate—osteoporosis	6.9e-05	0.00154	CcSEcCtD
Danazol—Musculoskeletal discomfort—Alendronate—osteoporosis	6.9e-05	0.00153	CcSEcCtD
Danazol—Flushing—Zoledronate—osteoporosis	6.89e-05	0.00153	CcSEcCtD
Danazol—Visual impairment—Conjugated Estrogens—osteoporosis	6.89e-05	0.00153	CcSEcCtD
Danazol—Nervousness—Pamidronate—osteoporosis	6.87e-05	0.00153	CcSEcCtD
Danazol—Back pain—Pamidronate—osteoporosis	6.84e-05	0.00152	CcSEcCtD
Danazol—Muscle spasms—Pamidronate—osteoporosis	6.8e-05	0.00151	CcSEcCtD
Danazol—Musculoskeletal discomfort—Raloxifene—osteoporosis	6.78e-05	0.00151	CcSEcCtD
Danazol—Dyspepsia—Estropipate—osteoporosis	6.77e-05	0.00151	CcSEcCtD
Danazol—Erythema multiforme—Conjugated Estrogens—osteoporosis	6.76e-05	0.0015	CcSEcCtD
Danazol—Musculoskeletal discomfort—Ibandronate—osteoporosis	6.71e-05	0.00149	CcSEcCtD
Danazol—Vertigo—Risedronate—osteoporosis	6.69e-05	0.00149	CcSEcCtD
Danazol—Syncope—Risedronate—osteoporosis	6.67e-05	0.00149	CcSEcCtD
Danazol—Dyspepsia—Alendronate—osteoporosis	6.66e-05	0.00148	CcSEcCtD
Danazol—Chills—Zoledronate—osteoporosis	6.66e-05	0.00148	CcSEcCtD
Danazol—Fatigue—Estropipate—osteoporosis	6.63e-05	0.00147	CcSEcCtD
Danazol—Paraesthesia—Ibandronate—osteoporosis	6.62e-05	0.00147	CcSEcCtD
Danazol—Musculoskeletal discomfort—Calcitriol—osteoporosis	6.57e-05	0.00146	CcSEcCtD
Danazol—Constipation—Estropipate—osteoporosis	6.57e-05	0.00146	CcSEcCtD
Danazol—Alopecia—Zoledronate—osteoporosis	6.56e-05	0.00146	CcSEcCtD
Danazol—Dyspepsia—Raloxifene—osteoporosis	6.55e-05	0.00146	CcSEcCtD
Danazol—Loss of consciousness—Risedronate—osteoporosis	6.54e-05	0.00146	CcSEcCtD
Danazol—Photosensitivity reaction—Estradiol—osteoporosis	6.52e-05	0.00145	CcSEcCtD
Danazol—Ethinyl Estradiol—SHBG—osteoporosis	6.52e-05	0.0363	CrCbGaD
Danazol—Weight increased—Estradiol—osteoporosis	6.5e-05	0.00145	CcSEcCtD
Danazol—Dyspepsia—Ibandronate—osteoporosis	6.49e-05	0.00144	CcSEcCtD
Danazol—Anxiety—Ethinyl Estradiol—osteoporosis	6.48e-05	0.00144	CcSEcCtD
Danazol—Constipation—Alendronate—osteoporosis	6.47e-05	0.00144	CcSEcCtD
Danazol—Hypertension—Risedronate—osteoporosis	6.43e-05	0.00143	CcSEcCtD
Danazol—Fatigue—Ibandronate—osteoporosis	6.35e-05	0.00141	CcSEcCtD
Danazol—Syncope—Pamidronate—osteoporosis	6.34e-05	0.00141	CcSEcCtD
Danazol—Arthralgia—Risedronate—osteoporosis	6.34e-05	0.00141	CcSEcCtD
Danazol—Leukopenia—Pamidronate—osteoporosis	6.33e-05	0.00141	CcSEcCtD
Danazol—Alopecia—Conjugated Estrogens—osteoporosis	6.32e-05	0.00141	CcSEcCtD
Danazol—Anxiety—Risedronate—osteoporosis	6.31e-05	0.00141	CcSEcCtD
Danazol—Constipation—Ibandronate—osteoporosis	6.3e-05	0.0014	CcSEcCtD
Danazol—Pruritus—Etidronic acid—osteoporosis	6.29e-05	0.0014	CcSEcCtD
Danazol—Acute coronary syndrome—Estradiol—osteoporosis	6.28e-05	0.0014	CcSEcCtD
Danazol—Norethindrone—SHBG—osteoporosis	6.27e-05	0.0349	CrCbGaD
Danazol—Back pain—Zoledronate—osteoporosis	6.25e-05	0.00139	CcSEcCtD
Danazol—Myocardial infarction—Estradiol—osteoporosis	6.25e-05	0.00139	CcSEcCtD
Danazol—Oedema—Ethinyl Estradiol—osteoporosis	6.23e-05	0.00139	CcSEcCtD
Danazol—Loss of consciousness—Pamidronate—osteoporosis	6.22e-05	0.00138	CcSEcCtD
Danazol—Muscle spasms—Zoledronate—osteoporosis	6.21e-05	0.00138	CcSEcCtD
Danazol—Jaundice—Estradiol—osteoporosis	6.21e-05	0.00138	CcSEcCtD
Danazol—Constipation—Calcitriol—osteoporosis	6.17e-05	0.00137	CcSEcCtD
Danazol—Convulsion—Pamidronate—osteoporosis	6.13e-05	0.00136	CcSEcCtD
Danazol—Hypertension—Pamidronate—osteoporosis	6.11e-05	0.00136	CcSEcCtD
Danazol—Tension—Conjugated Estrogens—osteoporosis	6.11e-05	0.00136	CcSEcCtD
Danazol—Urticaria—Estropipate—osteoporosis	6.11e-05	0.00136	CcSEcCtD
Danazol—Vision blurred—Zoledronate—osteoporosis	6.09e-05	0.00136	CcSEcCtD
Danazol—Haematuria—Estradiol—osteoporosis	6.08e-05	0.00135	CcSEcCtD
Danazol—Body temperature increased—Estropipate—osteoporosis	6.08e-05	0.00135	CcSEcCtD
Danazol—Tremor—Zoledronate—osteoporosis	6.05e-05	0.00135	CcSEcCtD
Danazol—Nervousness—Conjugated Estrogens—osteoporosis	6.04e-05	0.00135	CcSEcCtD
Danazol—Arthralgia—Pamidronate—osteoporosis	6.02e-05	0.00134	CcSEcCtD
Danazol—Back pain—Conjugated Estrogens—osteoporosis	6.02e-05	0.00134	CcSEcCtD
Danazol—Urticaria—Alendronate—osteoporosis	6.01e-05	0.00134	CcSEcCtD
Danazol—Anxiety—Pamidronate—osteoporosis	6e-05	0.00134	CcSEcCtD
Danazol—Body temperature increased—Alendronate—osteoporosis	5.98e-05	0.00133	CcSEcCtD
Danazol—Muscle spasms—Conjugated Estrogens—osteoporosis	5.98e-05	0.00133	CcSEcCtD
Danazol—Shock—Risedronate—osteoporosis	5.98e-05	0.00133	CcSEcCtD
Danazol—Methyltestosterone—SHBG—osteoporosis	5.95e-05	0.0332	CrCbGaD
Danazol—Body temperature increased—Raloxifene—osteoporosis	5.89e-05	0.00131	CcSEcCtD
Danazol—Vision blurred—Conjugated Estrogens—osteoporosis	5.86e-05	0.00131	CcSEcCtD
Danazol—Urticaria—Ibandronate—osteoporosis	5.86e-05	0.0013	CcSEcCtD
Danazol—Body temperature increased—Ibandronate—osteoporosis	5.83e-05	0.0013	CcSEcCtD
Danazol—Vertigo—Zoledronate—osteoporosis	5.81e-05	0.00129	CcSEcCtD
Danazol—Syncope—Zoledronate—osteoporosis	5.8e-05	0.00129	CcSEcCtD
Danazol—Leukopenia—Zoledronate—osteoporosis	5.78e-05	0.00129	CcSEcCtD
Danazol—Oedema—Pamidronate—osteoporosis	5.77e-05	0.00129	CcSEcCtD
Danazol—Haemoglobin—Estradiol—osteoporosis	5.75e-05	0.00128	CcSEcCtD
Danazol—Urticaria—Calcitriol—osteoporosis	5.73e-05	0.00128	CcSEcCtD
Danazol—Haemorrhage—Estradiol—osteoporosis	5.72e-05	0.00127	CcSEcCtD
Danazol—Palpitations—Zoledronate—osteoporosis	5.71e-05	0.00127	CcSEcCtD
Danazol—Body temperature increased—Calcitriol—osteoporosis	5.7e-05	0.00127	CcSEcCtD
Danazol—Shock—Pamidronate—osteoporosis	5.68e-05	0.00126	CcSEcCtD
Danazol—Loss of consciousness—Zoledronate—osteoporosis	5.68e-05	0.00126	CcSEcCtD
Danazol—Levonorgestrel—CYP19A1—osteoporosis	5.68e-05	0.0316	CrCbGaD
Danazol—Thrombocytopenia—Pamidronate—osteoporosis	5.65e-05	0.00126	CcSEcCtD
Danazol—Vomiting—Etidronic acid—osteoporosis	5.65e-05	0.00126	CcSEcCtD
Danazol—Tachycardia—Pamidronate—osteoporosis	5.64e-05	0.00125	CcSEcCtD
Danazol—Rash—Etidronic acid—osteoporosis	5.6e-05	0.00125	CcSEcCtD
Danazol—Convulsion—Zoledronate—osteoporosis	5.6e-05	0.00125	CcSEcCtD
Danazol—Dermatitis—Etidronic acid—osteoporosis	5.6e-05	0.00125	CcSEcCtD
Danazol—Vertigo—Conjugated Estrogens—osteoporosis	5.59e-05	0.00124	CcSEcCtD
Danazol—Hyperhidrosis—Pamidronate—osteoporosis	5.58e-05	0.00124	CcSEcCtD
Danazol—Syncope—Conjugated Estrogens—osteoporosis	5.58e-05	0.00124	CcSEcCtD
Danazol—Hypertension—Zoledronate—osteoporosis	5.58e-05	0.00124	CcSEcCtD
Danazol—Headache—Etidronic acid—osteoporosis	5.57e-05	0.00124	CcSEcCtD
Danazol—Musculoskeletal discomfort—Risedronate—osteoporosis	5.53e-05	0.00123	CcSEcCtD
Danazol—Asthenia—Estropipate—osteoporosis	5.51e-05	0.00123	CcSEcCtD
Danazol—Visual impairment—Estradiol—osteoporosis	5.51e-05	0.00123	CcSEcCtD
Danazol—Arthralgia—Zoledronate—osteoporosis	5.5e-05	0.00122	CcSEcCtD
Danazol—Palpitations—Conjugated Estrogens—osteoporosis	5.5e-05	0.00122	CcSEcCtD
Danazol—Anxiety—Zoledronate—osteoporosis	5.48e-05	0.00122	CcSEcCtD
Danazol—Loss of consciousness—Conjugated Estrogens—osteoporosis	5.47e-05	0.00122	CcSEcCtD
Danazol—Paraesthesia—Risedronate—osteoporosis	5.45e-05	0.00121	CcSEcCtD
Danazol—Pruritus—Estropipate—osteoporosis	5.44e-05	0.00121	CcSEcCtD
Danazol—Asthenia—Alendronate—osteoporosis	5.43e-05	0.00121	CcSEcCtD
Danazol—Erythema multiforme—Estradiol—osteoporosis	5.41e-05	0.0012	CcSEcCtD
Danazol—Convulsion—Conjugated Estrogens—osteoporosis	5.39e-05	0.0012	CcSEcCtD
Danazol—Fatigue—Ethinyl Estradiol—osteoporosis	5.37e-05	0.0012	CcSEcCtD
Danazol—Pruritus—Alendronate—osteoporosis	5.36e-05	0.00119	CcSEcCtD
Danazol—Dyspepsia—Risedronate—osteoporosis	5.35e-05	0.00119	CcSEcCtD
Danazol—Constipation—Ethinyl Estradiol—osteoporosis	5.33e-05	0.00119	CcSEcCtD
Danazol—Flushing—Estradiol—osteoporosis	5.31e-05	0.00118	CcSEcCtD
Danazol—Arthralgia—Conjugated Estrogens—osteoporosis	5.3e-05	0.00118	CcSEcCtD
Danazol—Asthenia—Ibandronate—osteoporosis	5.29e-05	0.00118	CcSEcCtD
Danazol—Anxiety—Conjugated Estrogens—osteoporosis	5.28e-05	0.00117	CcSEcCtD
Danazol—Nausea—Etidronic acid—osteoporosis	5.28e-05	0.00117	CcSEcCtD
Danazol—Oedema—Zoledronate—osteoporosis	5.27e-05	0.00117	CcSEcCtD
Danazol—Musculoskeletal discomfort—Pamidronate—osteoporosis	5.26e-05	0.00117	CcSEcCtD
Danazol—Fatigue—Risedronate—osteoporosis	5.24e-05	0.00117	CcSEcCtD
Danazol—Levonorgestrel—ESR1—osteoporosis	5.22e-05	0.0291	CrCbGaD
Danazol—Pruritus—Ibandronate—osteoporosis	5.21e-05	0.00116	CcSEcCtD
Danazol—Constipation—Risedronate—osteoporosis	5.19e-05	0.00116	CcSEcCtD
Danazol—Shock—Zoledronate—osteoporosis	5.19e-05	0.00115	CcSEcCtD
Danazol—Paraesthesia—Pamidronate—osteoporosis	5.18e-05	0.00115	CcSEcCtD
Danazol—Asthenia—Calcitriol—osteoporosis	5.18e-05	0.00115	CcSEcCtD
Danazol—Thrombocytopenia—Zoledronate—osteoporosis	5.16e-05	0.00115	CcSEcCtD
Danazol—Tachycardia—Zoledronate—osteoporosis	5.15e-05	0.00115	CcSEcCtD
Danazol—Chills—Estradiol—osteoporosis	5.13e-05	0.00114	CcSEcCtD
Danazol—Pruritus—Calcitriol—osteoporosis	5.1e-05	0.00114	CcSEcCtD
Danazol—Hyperhidrosis—Zoledronate—osteoporosis	5.1e-05	0.00113	CcSEcCtD
Danazol—Dyspepsia—Pamidronate—osteoporosis	5.08e-05	0.00113	CcSEcCtD
Danazol—Dizziness—Estropipate—osteoporosis	5.08e-05	0.00113	CcSEcCtD
Danazol—Oedema—Conjugated Estrogens—osteoporosis	5.08e-05	0.00113	CcSEcCtD
Danazol—Alopecia—Estradiol—osteoporosis	5.06e-05	0.00113	CcSEcCtD
Danazol—Dizziness—Alendronate—osteoporosis	5.01e-05	0.00111	CcSEcCtD
Danazol—Shock—Conjugated Estrogens—osteoporosis	5e-05	0.00111	CcSEcCtD
Danazol—Fatigue—Pamidronate—osteoporosis	4.98e-05	0.00111	CcSEcCtD
Danazol—Fluoxymesterone—ESR1—osteoporosis	4.98e-05	0.0277	CrCbGaD
Danazol—Tachycardia—Conjugated Estrogens—osteoporosis	4.96e-05	0.0011	CcSEcCtD
Danazol—Urticaria—Ethinyl Estradiol—osteoporosis	4.95e-05	0.0011	CcSEcCtD
Danazol—Constipation—Pamidronate—osteoporosis	4.94e-05	0.0011	CcSEcCtD
Danazol—Body temperature increased—Ethinyl Estradiol—osteoporosis	4.92e-05	0.0011	CcSEcCtD
Danazol—Dizziness—Raloxifene—osteoporosis	4.92e-05	0.0011	CcSEcCtD
Danazol—Hyperhidrosis—Conjugated Estrogens—osteoporosis	4.91e-05	0.00109	CcSEcCtD
Danazol—Tension—Estradiol—osteoporosis	4.89e-05	0.00109	CcSEcCtD
Danazol—Vomiting—Estropipate—osteoporosis	4.89e-05	0.00109	CcSEcCtD
Danazol—Dizziness—Ibandronate—osteoporosis	4.87e-05	0.00108	CcSEcCtD
Danazol—Rash—Estropipate—osteoporosis	4.85e-05	0.00108	CcSEcCtD
Danazol—Dermatitis—Estropipate—osteoporosis	4.84e-05	0.00108	CcSEcCtD
Danazol—Nervousness—Estradiol—osteoporosis	4.84e-05	0.00108	CcSEcCtD
Danazol—Urticaria—Risedronate—osteoporosis	4.83e-05	0.00107	CcSEcCtD
Danazol—Back pain—Estradiol—osteoporosis	4.82e-05	0.00107	CcSEcCtD
Danazol—Headache—Estropipate—osteoporosis	4.81e-05	0.00107	CcSEcCtD
Danazol—Vomiting—Alendronate—osteoporosis	4.81e-05	0.00107	CcSEcCtD
Danazol—Musculoskeletal discomfort—Zoledronate—osteoporosis	4.81e-05	0.00107	CcSEcCtD
Danazol—Body temperature increased—Risedronate—osteoporosis	4.8e-05	0.00107	CcSEcCtD
Danazol—Muscle spasms—Estradiol—osteoporosis	4.79e-05	0.00107	CcSEcCtD
Danazol—Rash—Alendronate—osteoporosis	4.77e-05	0.00106	CcSEcCtD
Danazol—Dermatitis—Alendronate—osteoporosis	4.77e-05	0.00106	CcSEcCtD
Danazol—Headache—Alendronate—osteoporosis	4.74e-05	0.00106	CcSEcCtD
Danazol—Paraesthesia—Zoledronate—osteoporosis	4.74e-05	0.00105	CcSEcCtD
Danazol—Vomiting—Raloxifene—osteoporosis	4.73e-05	0.00105	CcSEcCtD
Danazol—Rash—Raloxifene—osteoporosis	4.69e-05	0.00104	CcSEcCtD
Danazol—Dermatitis—Raloxifene—osteoporosis	4.69e-05	0.00104	CcSEcCtD
Danazol—Vomiting—Ibandronate—osteoporosis	4.69e-05	0.00104	CcSEcCtD
Danazol—Tremor—Estradiol—osteoporosis	4.67e-05	0.00104	CcSEcCtD
Danazol—Headache—Raloxifene—osteoporosis	4.66e-05	0.00104	CcSEcCtD
Danazol—Rash—Ibandronate—osteoporosis	4.65e-05	0.00103	CcSEcCtD
Danazol—Dermatitis—Ibandronate—osteoporosis	4.64e-05	0.00103	CcSEcCtD
Danazol—Dyspepsia—Zoledronate—osteoporosis	4.64e-05	0.00103	CcSEcCtD
Danazol—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	4.63e-05	0.00103	CcSEcCtD
Danazol—Headache—Ibandronate—osteoporosis	4.62e-05	0.00103	CcSEcCtD
Danazol—Vomiting—Calcitriol—osteoporosis	4.59e-05	0.00102	CcSEcCtD
Danazol—Nausea—Estropipate—osteoporosis	4.57e-05	0.00102	CcSEcCtD
Danazol—Body temperature increased—Pamidronate—osteoporosis	4.56e-05	0.00102	CcSEcCtD
Danazol—Paraesthesia—Conjugated Estrogens—osteoporosis	4.56e-05	0.00101	CcSEcCtD
Danazol—Rash—Calcitriol—osteoporosis	4.55e-05	0.00101	CcSEcCtD
Danazol—Fatigue—Zoledronate—osteoporosis	4.55e-05	0.00101	CcSEcCtD
Danazol—Dermatitis—Calcitriol—osteoporosis	4.54e-05	0.00101	CcSEcCtD
Danazol—Headache—Calcitriol—osteoporosis	4.52e-05	0.00101	CcSEcCtD
Danazol—Constipation—Zoledronate—osteoporosis	4.51e-05	0.001	CcSEcCtD
Danazol—Nausea—Alendronate—osteoporosis	4.5e-05	0.001	CcSEcCtD
Danazol—Hydrocortisone—SHBG—osteoporosis	4.48e-05	0.025	CrCbGaD
Danazol—Vertigo—Estradiol—osteoporosis	4.47e-05	0.000996	CcSEcCtD
Danazol—Dyspepsia—Conjugated Estrogens—osteoporosis	4.47e-05	0.000995	CcSEcCtD
Danazol—Asthenia—Ethinyl Estradiol—osteoporosis	4.47e-05	0.000995	CcSEcCtD
Danazol—Syncope—Estradiol—osteoporosis	4.47e-05	0.000994	CcSEcCtD
Danazol—Nausea—Raloxifene—osteoporosis	4.42e-05	0.000984	CcSEcCtD
Danazol—Pruritus—Ethinyl Estradiol—osteoporosis	4.41e-05	0.000981	CcSEcCtD
Danazol—Ethinyl Estradiol—ESR1—osteoporosis	4.4e-05	0.0245	CrCbGaD
Danazol—Palpitations—Estradiol—osteoporosis	4.4e-05	0.000979	CcSEcCtD
Danazol—Fatigue—Conjugated Estrogens—osteoporosis	4.38e-05	0.000974	CcSEcCtD
Danazol—Nausea—Ibandronate—osteoporosis	4.38e-05	0.000974	CcSEcCtD
Danazol—Loss of consciousness—Estradiol—osteoporosis	4.38e-05	0.000974	CcSEcCtD
Danazol—Methyltestosterone—CYP19A1—osteoporosis	4.37e-05	0.0243	CrCbGaD
Danazol—Asthenia—Risedronate—osteoporosis	4.36e-05	0.00097	CcSEcCtD
Danazol—Constipation—Conjugated Estrogens—osteoporosis	4.34e-05	0.000967	CcSEcCtD
Danazol—Hypertension—Estradiol—osteoporosis	4.3e-05	0.000957	CcSEcCtD
Danazol—Pruritus—Risedronate—osteoporosis	4.3e-05	0.000956	CcSEcCtD
Danazol—Nausea—Calcitriol—osteoporosis	4.29e-05	0.000954	CcSEcCtD
Danazol—Arthralgia—Estradiol—osteoporosis	4.24e-05	0.000944	CcSEcCtD
Danazol—Anxiety—Estradiol—osteoporosis	4.23e-05	0.00094	CcSEcCtD
Danazol—Urticaria—Zoledronate—osteoporosis	4.19e-05	0.000933	CcSEcCtD
Danazol—Body temperature increased—Zoledronate—osteoporosis	4.17e-05	0.000928	CcSEcCtD
Danazol—Asthenia—Pamidronate—osteoporosis	4.14e-05	0.000922	CcSEcCtD
Danazol—Dizziness—Ethinyl Estradiol—osteoporosis	4.12e-05	0.000917	CcSEcCtD
Danazol—Pruritus—Pamidronate—osteoporosis	4.09e-05	0.000909	CcSEcCtD
Danazol—Oedema—Estradiol—osteoporosis	4.06e-05	0.000905	CcSEcCtD
Danazol—Urticaria—Conjugated Estrogens—osteoporosis	4.03e-05	0.000898	CcSEcCtD
Danazol—Dizziness—Risedronate—osteoporosis	4.02e-05	0.000894	CcSEcCtD
Danazol—Body temperature increased—Conjugated Estrogens—osteoporosis	4.01e-05	0.000893	CcSEcCtD
Danazol—Shock—Estradiol—osteoporosis	4e-05	0.00089	CcSEcCtD
Danazol—Tachycardia—Estradiol—osteoporosis	3.97e-05	0.000883	CcSEcCtD
Danazol—Vomiting—Ethinyl Estradiol—osteoporosis	3.96e-05	0.000882	CcSEcCtD
Danazol—Hyperhidrosis—Estradiol—osteoporosis	3.93e-05	0.000874	CcSEcCtD
Danazol—Rash—Ethinyl Estradiol—osteoporosis	3.93e-05	0.000874	CcSEcCtD
Danazol—Dermatitis—Ethinyl Estradiol—osteoporosis	3.92e-05	0.000873	CcSEcCtD
Danazol—Headache—Ethinyl Estradiol—osteoporosis	3.9e-05	0.000869	CcSEcCtD
Danazol—Vomiting—Risedronate—osteoporosis	3.86e-05	0.00086	CcSEcCtD
Danazol—Rash—Risedronate—osteoporosis	3.83e-05	0.000852	CcSEcCtD
Danazol—Dermatitis—Risedronate—osteoporosis	3.83e-05	0.000852	CcSEcCtD
Danazol—Dizziness—Pamidronate—osteoporosis	3.82e-05	0.00085	CcSEcCtD
Danazol—Headache—Risedronate—osteoporosis	3.81e-05	0.000847	CcSEcCtD
Danazol—Asthenia—Zoledronate—osteoporosis	3.78e-05	0.000842	CcSEcCtD
Danazol—Pruritus—Zoledronate—osteoporosis	3.73e-05	0.00083	CcSEcCtD
Danazol—Musculoskeletal discomfort—Estradiol—osteoporosis	3.7e-05	0.000824	CcSEcCtD
Danazol—Nausea—Ethinyl Estradiol—osteoporosis	3.7e-05	0.000824	CcSEcCtD
Danazol—Vomiting—Pamidronate—osteoporosis	3.67e-05	0.000817	CcSEcCtD
Danazol—Progesterone—SHBG—osteoporosis	3.65e-05	0.0203	CrCbGaD
Danazol—Paraesthesia—Estradiol—osteoporosis	3.65e-05	0.000812	CcSEcCtD
Danazol—Asthenia—Conjugated Estrogens—osteoporosis	3.64e-05	0.000811	CcSEcCtD
Danazol—Rash—Pamidronate—osteoporosis	3.64e-05	0.00081	CcSEcCtD
Danazol—Dermatitis—Pamidronate—osteoporosis	3.64e-05	0.00081	CcSEcCtD
Danazol—Headache—Pamidronate—osteoporosis	3.62e-05	0.000805	CcSEcCtD
Danazol—Nausea—Risedronate—osteoporosis	3.61e-05	0.000803	CcSEcCtD
Danazol—Pruritus—Conjugated Estrogens—osteoporosis	3.59e-05	0.0008	CcSEcCtD
Danazol—Dyspepsia—Estradiol—osteoporosis	3.58e-05	0.000796	CcSEcCtD
Danazol—Fatigue—Estradiol—osteoporosis	3.5e-05	0.00078	CcSEcCtD
Danazol—Dizziness—Zoledronate—osteoporosis	3.49e-05	0.000776	CcSEcCtD
Danazol—Constipation—Estradiol—osteoporosis	3.48e-05	0.000774	CcSEcCtD
Danazol—Testosterone—SHBG—osteoporosis	3.45e-05	0.0192	CrCbGaD
Danazol—Nausea—Pamidronate—osteoporosis	3.43e-05	0.000763	CcSEcCtD
Danazol—Dizziness—Conjugated Estrogens—osteoporosis	3.36e-05	0.000747	CcSEcCtD
Danazol—Vomiting—Zoledronate—osteoporosis	3.35e-05	0.000746	CcSEcCtD
Danazol—Rash—Zoledronate—osteoporosis	3.33e-05	0.00074	CcSEcCtD
Danazol—Dermatitis—Zoledronate—osteoporosis	3.32e-05	0.000739	CcSEcCtD
Danazol—Headache—Zoledronate—osteoporosis	3.3e-05	0.000735	CcSEcCtD
Danazol—Vomiting—Conjugated Estrogens—osteoporosis	3.23e-05	0.000719	CcSEcCtD
Danazol—Urticaria—Estradiol—osteoporosis	3.23e-05	0.000719	CcSEcCtD
Danazol—Body temperature increased—Estradiol—osteoporosis	3.21e-05	0.000715	CcSEcCtD
Danazol—Rash—Conjugated Estrogens—osteoporosis	3.2e-05	0.000713	CcSEcCtD
Danazol—Dermatitis—Conjugated Estrogens—osteoporosis	3.2e-05	0.000712	CcSEcCtD
Danazol—Headache—Conjugated Estrogens—osteoporosis	3.18e-05	0.000708	CcSEcCtD
Danazol—Nausea—Zoledronate—osteoporosis	3.13e-05	0.000697	CcSEcCtD
Danazol—Nausea—Conjugated Estrogens—osteoporosis	3.02e-05	0.000671	CcSEcCtD
Danazol—Asthenia—Estradiol—osteoporosis	2.92e-05	0.000649	CcSEcCtD
Danazol—Pruritus—Estradiol—osteoporosis	2.88e-05	0.00064	CcSEcCtD
Danazol—Dizziness—Estradiol—osteoporosis	2.69e-05	0.000598	CcSEcCtD
Danazol—Vomiting—Estradiol—osteoporosis	2.58e-05	0.000575	CcSEcCtD
Danazol—Rash—Estradiol—osteoporosis	2.56e-05	0.00057	CcSEcCtD
Danazol—Dermatitis—Estradiol—osteoporosis	2.56e-05	0.00057	CcSEcCtD
Danazol—Headache—Estradiol—osteoporosis	2.55e-05	0.000567	CcSEcCtD
Danazol—Testosterone—CYP19A1—osteoporosis	2.53e-05	0.0141	CrCbGaD
Danazol—Progesterone—ESR1—osteoporosis	2.47e-05	0.0137	CrCbGaD
Danazol—Nausea—Estradiol—osteoporosis	2.41e-05	0.000537	CcSEcCtD
Danazol—PGR—Signaling Pathways—CALCR—osteoporosis	2.06e-05	0.000962	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTH1R—osteoporosis	2.06e-05	0.000962	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—MYC—osteoporosis	2.06e-05	0.000961	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—TGFB1—osteoporosis	2.05e-05	0.000959	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TLN1—osteoporosis	2.04e-05	0.000955	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—MYC—osteoporosis	2.01e-05	0.000939	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TGFB1—osteoporosis	2e-05	0.000937	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.96e-05	0.000914	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	1.95e-05	0.000912	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.94e-05	0.000909	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IRS1—osteoporosis	1.94e-05	0.000907	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—LEP—osteoporosis	1.93e-05	0.000903	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—P4HB—osteoporosis	1.93e-05	0.0009	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—VDR—osteoporosis	1.92e-05	0.000896	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—POMC—osteoporosis	1.89e-05	0.000884	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTH—osteoporosis	1.87e-05	0.000876	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RAP1A—osteoporosis	1.84e-05	0.000861	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—ESR2—osteoporosis	1.84e-05	0.00086	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CNR2—osteoporosis	1.83e-05	0.000854	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6R—osteoporosis	1.82e-05	0.000852	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NFATC1—osteoporosis	1.8e-05	0.00084	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	1.79e-05	0.000836	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—FDPS—osteoporosis	1.78e-05	0.000834	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PKM—osteoporosis	1.78e-05	0.000834	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—DKK1—osteoporosis	1.78e-05	0.000833	CbGpPWpGaD
Danazol—ESR1—Gene Expression—U2AF1—osteoporosis	1.78e-05	0.000832	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.76e-05	0.000824	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—P4HB—osteoporosis	1.76e-05	0.000823	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	1.75e-05	0.000817	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IL6—osteoporosis	1.73e-05	0.000809	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.73e-05	0.000808	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	1.72e-05	0.000806	CbGpPWpGaD
Danazol—AR—Gene Expression—RPL24—osteoporosis	1.72e-05	0.000803	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—WNT1—osteoporosis	1.72e-05	0.000802	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTH—osteoporosis	1.71e-05	0.000801	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GPD2—osteoporosis	1.69e-05	0.00079	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PGLS—osteoporosis	1.69e-05	0.00079	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RAP1A—osteoporosis	1.68e-05	0.000787	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FGA—osteoporosis	1.67e-05	0.000781	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CNR2—osteoporosis	1.67e-05	0.000781	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.66e-05	0.000777	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—POMC—osteoporosis	1.66e-05	0.000776	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—ADCY5—osteoporosis	1.66e-05	0.000775	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—ADCY5—osteoporosis	1.65e-05	0.000769	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NFATC1—osteoporosis	1.64e-05	0.000768	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MGLL—osteoporosis	1.63e-05	0.000764	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—DKK1—osteoporosis	1.63e-05	0.000762	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—IGF1—osteoporosis	1.6e-05	0.000746	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LRP5—osteoporosis	1.59e-05	0.000746	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—WNT1—osteoporosis	1.57e-05	0.000734	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTHLH—osteoporosis	1.55e-05	0.000726	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—BMP2—osteoporosis	1.55e-05	0.000726	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ATIC—osteoporosis	1.55e-05	0.000723	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PNP—osteoporosis	1.55e-05	0.000723	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FGA—osteoporosis	1.53e-05	0.000714	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LRP6—osteoporosis	1.53e-05	0.000713	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FGB—osteoporosis	1.52e-05	0.00071	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL6—osteoporosis	1.51e-05	0.000706	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—ADCY5—osteoporosis	1.51e-05	0.000704	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.5e-05	0.0007	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PSMA2—osteoporosis	1.47e-05	0.000686	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PSMA5—osteoporosis	1.47e-05	0.000686	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—ESR1—osteoporosis	1.46e-05	0.000684	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—VDR—osteoporosis	1.46e-05	0.000682	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTHLH—osteoporosis	1.42e-05	0.000664	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—BMP2—osteoporosis	1.42e-05	0.000664	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—ESR2—osteoporosis	1.42e-05	0.000662	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—MYC—osteoporosis	1.41e-05	0.000659	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FGB—osteoporosis	1.39e-05	0.00065	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—IL6—osteoporosis	1.38e-05	0.000647	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CALCA—osteoporosis	1.37e-05	0.000639	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PSMA2—osteoporosis	1.34e-05	0.000627	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PSMA5—osteoporosis	1.34e-05	0.000627	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SOST—osteoporosis	1.33e-05	0.000624	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RPL24—osteoporosis	1.32e-05	0.000618	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—OXCT1—osteoporosis	1.31e-05	0.000615	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CA2—osteoporosis	1.31e-05	0.000615	CbGpPWpGaD
Danazol—PGR—Gene Expression—PSMA2—osteoporosis	1.3e-05	0.000608	CbGpPWpGaD
Danazol—PGR—Gene Expression—PSMA5—osteoporosis	1.3e-05	0.000608	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TLN1—osteoporosis	1.29e-05	0.000602	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.28e-05	0.000599	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MGLL—osteoporosis	1.28e-05	0.000599	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—osteoporosis	1.28e-05	0.000598	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CALCA—osteoporosis	1.25e-05	0.000584	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KL—osteoporosis	1.24e-05	0.00058	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—POMC—osteoporosis	1.22e-05	0.00057	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MYC—osteoporosis	1.21e-05	0.000567	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—POMC—osteoporosis	1.21e-05	0.000566	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CALCR—osteoporosis	1.21e-05	0.000564	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTH1R—osteoporosis	1.21e-05	0.000564	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6R—osteoporosis	1.18e-05	0.000552	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.17e-05	0.000546	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.17e-05	0.000545	CbGpPWpGaD
Danazol—PGR—Gene Expression—ESR2—osteoporosis	1.16e-05	0.000543	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KL—osteoporosis	1.14e-05	0.000531	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—VDR—osteoporosis	1.12e-05	0.000526	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—ESR1—osteoporosis	1.12e-05	0.000522	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—P4HB—osteoporosis	1.11e-05	0.000519	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—POMC—osteoporosis	1.11e-05	0.000518	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—IDH2—osteoporosis	1.09e-05	0.000509	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.09e-05	0.000509	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MYC—osteoporosis	1.09e-05	0.000508	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTH—osteoporosis	1.08e-05	0.000505	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6R—osteoporosis	1.08e-05	0.000505	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RAP1A—osteoporosis	1.06e-05	0.000496	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CNR2—osteoporosis	1.05e-05	0.000492	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.04e-05	0.000486	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NFATC1—osteoporosis	1.04e-05	0.000484	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL6—osteoporosis	1.03e-05	0.000483	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—DKK1—osteoporosis	1.03e-05	0.00048	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP27A1—osteoporosis	1.02e-05	0.000479	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ACP5—osteoporosis	9.96e-06	0.000466	CbGpPWpGaD
Danazol—AR—Gene Expression—PSMA2—osteoporosis	9.91e-06	0.000463	CbGpPWpGaD
Danazol—AR—Gene Expression—PSMA5—osteoporosis	9.91e-06	0.000463	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—WNT1—osteoporosis	9.9e-06	0.000463	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.84e-06	0.00046	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ADCY5—osteoporosis	9.72e-06	0.000454	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGA—osteoporosis	9.63e-06	0.00045	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MGLL—osteoporosis	9.59e-06	0.000448	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SPP1—osteoporosis	9.41e-06	0.00044	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LRP5—osteoporosis	9.36e-06	0.000438	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TPI1—osteoporosis	9.26e-06	0.000433	CbGpPWpGaD
Danazol—PGR—Gene Expression—VDR—osteoporosis	9.23e-06	0.000431	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	9.18e-06	0.000429	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	9.06e-06	0.000423	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9e-06	0.000421	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	8.98e-06	0.00042	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LRP6—osteoporosis	8.95e-06	0.000419	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTHLH—osteoporosis	8.95e-06	0.000419	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BMP2—osteoporosis	8.95e-06	0.000419	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ADCY5—osteoporosis	8.89e-06	0.000416	CbGpPWpGaD
Danazol—AR—Gene Expression—ESR2—osteoporosis	8.86e-06	0.000414	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGB—osteoporosis	8.76e-06	0.00041	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—P4HB—osteoporosis	8.71e-06	0.000407	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SPP1—osteoporosis	8.6e-06	0.000402	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GAPDH—osteoporosis	8.55e-06	0.0004	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IRS2—osteoporosis	8.51e-06	0.000398	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PSMA2—osteoporosis	8.46e-06	0.000395	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PSMA5—osteoporosis	8.46e-06	0.000395	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.38e-06	0.000392	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—RAP1A—osteoporosis	8.33e-06	0.000389	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LEP—osteoporosis	8.32e-06	0.000389	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6—osteoporosis	8.12e-06	0.00038	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ESR1—osteoporosis	7.95e-06	0.000372	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CALCA—osteoporosis	7.88e-06	0.000369	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IRS2—osteoporosis	7.78e-06	0.000364	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PSMA2—osteoporosis	7.64e-06	0.000357	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PSMA5—osteoporosis	7.64e-06	0.000357	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MYC—osteoporosis	7.62e-06	0.000356	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LEP—osteoporosis	7.61e-06	0.000356	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TLN1—osteoporosis	7.56e-06	0.000353	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IRS1—osteoporosis	7.43e-06	0.000347	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ESR1—osteoporosis	7.27e-06	0.00034	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.26e-06	0.000339	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KL—osteoporosis	7.16e-06	0.000335	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—POMC—osteoporosis	7.15e-06	0.000334	CbGpPWpGaD
Danazol—PGR—Gene Expression—ESR1—osteoporosis	7.05e-06	0.00033	CbGpPWpGaD
Danazol—AR—Gene Expression—VDR—osteoporosis	7.03e-06	0.000329	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6R—osteoporosis	6.98e-06	0.000326	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF1—osteoporosis	6.88e-06	0.000322	CbGpPWpGaD
Danazol—ESR1—Gene Expression—ESR2—osteoporosis	6.82e-06	0.000319	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IRS1—osteoporosis	6.79e-06	0.000317	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ENO1—osteoporosis	6.73e-06	0.000315	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PSMA2—osteoporosis	6.63e-06	0.00031	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PSMA5—osteoporosis	6.63e-06	0.00031	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—POMC—osteoporosis	6.54e-06	0.000306	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—P4HB—osteoporosis	6.52e-06	0.000305	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6R—osteoporosis	6.38e-06	0.000298	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTH—osteoporosis	6.34e-06	0.000296	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF1—osteoporosis	6.29e-06	0.000294	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RAP1A—osteoporosis	6.23e-06	0.000291	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CNR2—osteoporosis	6.18e-06	0.000289	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NFATC1—osteoporosis	6.08e-06	0.000284	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DKK1—osteoporosis	6.03e-06	0.000282	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—WNT1—osteoporosis	5.81e-06	0.000272	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MYC—osteoporosis	5.8e-06	0.000271	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGA—osteoporosis	5.65e-06	0.000264	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADCY5—osteoporosis	5.61e-06	0.000262	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—POMC—osteoporosis	5.52e-06	0.000258	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SPP1—osteoporosis	5.42e-06	0.000254	CbGpPWpGaD
Danazol—ESR1—Gene Expression—VDR—osteoporosis	5.41e-06	0.000253	CbGpPWpGaD
Danazol—AR—Gene Expression—ESR1—osteoporosis	5.37e-06	0.000251	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—osteoporosis	5.26e-06	0.000246	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTHLH—osteoporosis	5.25e-06	0.000246	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BMP2—osteoporosis	5.25e-06	0.000246	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PKM—osteoporosis	5.2e-06	0.000243	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FDPS—osteoporosis	5.2e-06	0.000243	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGB—osteoporosis	5.14e-06	0.00024	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PSMA5—osteoporosis	4.96e-06	0.000232	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PSMA2—osteoporosis	4.96e-06	0.000232	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPD2—osteoporosis	4.93e-06	0.000231	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PGLS—osteoporosis	4.93e-06	0.000231	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IRS2—osteoporosis	4.91e-06	0.000229	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—osteoporosis	4.81e-06	0.000225	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEP—osteoporosis	4.8e-06	0.000224	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CALCA—osteoporosis	4.63e-06	0.000216	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ESR1—osteoporosis	4.58e-06	0.000214	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PNP—osteoporosis	4.51e-06	0.000211	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ATIC—osteoporosis	4.51e-06	0.000211	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—osteoporosis	4.47e-06	0.000209	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ADCY5—osteoporosis	4.4e-06	0.000206	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GPX1—osteoporosis	4.38e-06	0.000205	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IRS1—osteoporosis	4.28e-06	0.0002	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KL—osteoporosis	4.2e-06	0.000196	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—osteoporosis	4.13e-06	0.000193	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—POMC—osteoporosis	4.12e-06	0.000193	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—osteoporosis	4.12e-06	0.000193	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—osteoporosis	4.04e-06	0.000189	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6R—osteoporosis	4.02e-06	0.000188	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1—osteoporosis	3.97e-06	0.000185	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA2—osteoporosis	3.84e-06	0.000179	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—OXCT1—osteoporosis	3.84e-06	0.000179	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—osteoporosis	3.78e-06	0.000177	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—osteoporosis	3.77e-06	0.000176	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MGLL—osteoporosis	3.74e-06	0.000175	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—osteoporosis	3.67e-06	0.000171	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADCY5—osteoporosis	3.29e-06	0.000154	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—POMC—osteoporosis	3.23e-06	0.000151	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SPP1—osteoporosis	3.18e-06	0.000149	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—IDH2—osteoporosis	3.18e-06	0.000149	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—osteoporosis	3.11e-06	0.000145	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.99e-06	0.00014	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACP5—osteoporosis	2.91e-06	0.000136	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IRS2—osteoporosis	2.88e-06	0.000135	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—osteoporosis	2.84e-06	0.000133	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEP—osteoporosis	2.82e-06	0.000132	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—osteoporosis	2.79e-06	0.000131	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TPI1—osteoporosis	2.7e-06	0.000126	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—P4HB—osteoporosis	2.54e-06	0.000119	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IRS1—osteoporosis	2.51e-06	0.000118	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GAPDH—osteoporosis	2.49e-06	0.000117	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—RAP1A—osteoporosis	2.43e-06	0.000114	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—POMC—osteoporosis	2.42e-06	0.000113	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—osteoporosis	2.38e-06	0.000111	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—osteoporosis	2.38e-06	0.000111	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6R—osteoporosis	2.36e-06	0.00011	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1—osteoporosis	2.33e-06	0.000109	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—osteoporosis	2.15e-06	0.000101	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENO1—osteoporosis	1.96e-06	9.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PSMA2—osteoporosis	1.94e-06	9.05e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PSMA5—osteoporosis	1.94e-06	9.05e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—osteoporosis	1.79e-06	8.38e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.57e-06	7.34e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—osteoporosis	1.4e-06	6.54e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—osteoporosis	1.4e-06	6.53e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADCY5—osteoporosis	1.28e-06	6e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPX1—osteoporosis	1.28e-06	5.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—osteoporosis	1.18e-06	5.52e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—osteoporosis	1.05e-06	4.92e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—POMC—osteoporosis	9.44e-07	4.41e-05	CbGpPWpGaD
